Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
03/2005
03/31/2005US20050070588 Imidazolyl inhibitors of 15-lipoxygenase
03/31/2005US20050070581 such as 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxybenzylidene-2,4-thiazolidinedione; Hodgkin's disease
03/31/2005US20050070571 Such as N6-[6-(2-dimethylaminoethylamino)-4-methylsulfanyl-[1,3,5]triazin-2-yl]-2-methylquinoline-4,6-diamine, which stabilizes DNA in G-quadruplex structures (guanine tetrads); anticancer agents
03/31/2005US20050070570 6,8-Dimethoxy isoquinoline derivatives; useful in the treatment or alleviation of disorders and conditions associated with, or dependent on membrane potential or conductance of cells in mammals, including humans, such as asthma, cystic fibrosis, obstructive pulmonary disease, convulsions, vascular spasms
03/31/2005US20050070566 Imidazoquinoline derivatives
03/31/2005US20050070562 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
03/31/2005US20050070561 For example, 2-(3-{[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinazolin-4-yl]amino}-1H-pyrazol-5-yl)-N-phenylacetamide; use in the treatment of certain diseases, in particular to proliferative disease such as cancer
03/31/2005US20050070559 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3
03/31/2005US20050070549 heterocylic amines such as 2-(5-{3-[4-(4-Chloro-2-methyl-phenyl)-piperazin-1-yl]-propylidene}-5,11-dihydro-10-oxa-1-aza-dibenzo[a,d]cyclohepten-7-yl)-propan-2-ol, used for treating diseases associated with aberrant leukocyte recruitment and/or activation
03/31/2005US20050070535 Antidiabetic agents; obesity; controlling appetite
03/31/2005US20050070531 Using such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile to treat cancer and/or autoimmune disorder
03/31/2005US20050070530 Dipeptidyl peptidase inhibitors
03/31/2005US20050070521 Alkyl ether derivatives or salts thereof
03/31/2005US20050070520 Aza-cyclic compounds as modulators of acetylcholine receptors
03/31/2005US20050069555 Vaccine adjuvants; hepatitis c virus; modulation immunology response
03/31/2005CA2538874A1 Benzopyranone compounds, compositions thereof, and methods of treatment therewith
03/31/2005CA2538855A1 1,4-disubstituted isoquinilone derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases
03/31/2005CA2538590A1 Novel gamma secretase inhibitors
03/31/2005CA2538381A1 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (gsk-3)
03/30/2005EP1519236A2 Organophotoreceptor with an epoxy-modified charge transport compound having an azine group
03/30/2005EP1519192A2 HIV Protease inhibitor conjugates and antibodies useful in ummunoassay
03/30/2005EP1518855A1 Diaminopyrimidinecarboxa mide derivative
03/30/2005EP1517975A2 Polymerizable, luminescent compounds and mixtures, luminescent polymer materials and their use
03/30/2005EP1517908A2 Novel benzimidazole derivatives
03/30/2005EP1517906A1 Method for the production of 1,2,4-triazolylmethyl-oxiranes
03/30/2005EP1517898A1 Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases
03/30/2005EP1517897A2 Benzimidazole compounds and their use as estrogen agonists/antagonists
03/30/2005EP1517686A2 Use of dantrolene, a ryanodine antagonist, in treating neural injury
03/30/2005EP1446496A4 Methods for ligand discovery
03/30/2005EP1250092B1 Method for preventing fluorescence quenching
03/30/2005EP1075467B1 Pyrazole derivatives as p-38 map kinase inhibitors
03/30/2005CN1602313A 铑和铱的络合物 Complexes of rhodium and iridium
03/30/2005CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
03/29/2005US6872851 Melatonergic receptors; antiinflammatory agents; anticancer agents
03/29/2005US6872839 Stabilizers; heat resistance, colorfastness, photostability
03/29/2005US6872837 Taxanes having a c10 Heterosubstituted acetate substituent
03/29/2005US6872745 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
03/29/2005US6872735 LFA-1 antagonist compounds
03/29/2005US6872730 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists
03/29/2005US6872728 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
03/29/2005US6872726 Fluorinated di-aryl urea compounds
03/29/2005CA2102750C Substituted triazolinones
03/29/2005CA2097444C Angiotensin ii antagonist imidazole derivatives, their preparation and their therapeutic use
03/24/2005WO2005026165A1 Quinolone antibacterial agents
03/24/2005WO2005026163A1 Dioxolane derivatives as cell adhesion inhibitors
03/24/2005WO2005026158A1 2,4 di (hetero) -arylamino-pyrimidine derivatives as zap-70 and/or syk inhibitors
03/24/2005WO2005026154A1 Quinolone antibacterial agents
03/24/2005WO2005026150A1 Quinazoline derivatives as tyrosine kinase inhibitors
03/24/2005WO2005026145A2 Quinolone antibacterial agents
03/24/2005WO2005026143A1 Coumarins as inos inhibitors
03/24/2005WO2005026130A1 2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders
03/24/2005WO2005026129A1 Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases
03/24/2005WO2005026127A1 Plasminogen activator inhibitor-1 inhibitor
03/24/2005WO2005026123A1 2-pyridone derivatives as neutrophil elastase inhibitors and their use
03/24/2005WO2005026120A1 Matrix metalloproteinase inhibitors
03/24/2005WO2005025681A2 A system for and a method of manufacturing personal golf putters
03/24/2005WO2005025507A2 Dihydropyridine compounds for treating or preventing metabolic disorders
03/24/2005WO2005011657A3 Piperazine derivatives and their use as therapeutic agents
03/24/2005WO2005003101A3 Pyrazine and pyridine derivatives as rho kinase inhibitors
03/24/2005WO2004092144A3 Quinazoline compounds useful as p38 kinase inhibitors
03/24/2005WO2004073619A3 Ccr8 antagonists
03/24/2005WO2004072101A3 Phenylglycine derivatives useful as serine protease inhibitors
03/24/2005WO2004067510A8 3,6-disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
03/24/2005WO2004064730A3 Compounds, compositions and methods
03/24/2005WO2004046162A8 Non-steroidal fxr agonists
03/24/2005WO2004046113A3 Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors
03/24/2005WO2004041161A3 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity
03/24/2005WO2004039795A3 Amide compounds for the treatment of hyperlipidemia
03/24/2005WO2004016607A8 Inhibition of phosphoinositide 3-kinase beta
03/24/2005WO2004004632A8 Flavone derivatives as inhibitors of cyclin-dependent kinases
03/24/2005US20050065191 Central nervous system disorders; therapy for diseases of glutamate receptor signal transmission
03/24/2005US20050065179 Novel derivatives of benzimidazole and imidazo-pyridine and their use as medicaments
03/24/2005US20050065166 Herbicides; plant safening agents
03/24/2005US20050065163 Platelet adenosine diphosphate receptor antagonists
03/24/2005US20050065161 Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
03/24/2005US20050065150 Lipoxygenase moderators; autoimmune disease; neurodegenerative disease; respiratory system disorders; cardiovascular disorders; Alzheimer's disease; Parkinson's disease; amyotropic lateral sclerosis
03/24/2005US20050065149 Neurodegenerative disorders; antiinflammatory agents; strokes; antiischemic agents; neuropathic pain; brain disorders; antiepileptic agents; Parkinson's disease ; amyotropic lateral sclerosis; Alzheimer's disease; antidiabetic agents
03/24/2005US20050065148 Dipeptidyl peptidase inhibitors
03/24/2005US20050065099 Treatment of mitochondrial diseases
03/24/2005US20050065095 Antibacterial agents
03/24/2005CA2538909A1 2,4 di (hetero) -arylamino-pyrimidine derivatives as zap-70 and/or syk inhibitors
03/24/2005CA2538420A1 Quinolone antibacterial agents
03/24/2005CA2538413A1 2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders
03/24/2005CA2538315A1 Matrix metalloproteinase inhibitors
03/24/2005CA2538188A1 Dihydropyridine compounds for treating or preventing metabolic disorders
03/24/2005CA2482232A1 Protease inhibitor conjugates and antibodies useful in immunoassay
03/23/2005EP1516877A1 Amine derivatives as protease inhibitors
03/23/2005EP1516876A1 Mediators of hedgehog signalling pathways, compositions and uses related thereto
03/23/2005EP1516875A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
03/23/2005EP1516874A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
03/23/2005EP1515965A1 Phenylaminopyrimidines and their use as rho-kinase inhibitors
03/23/2005EP1515964A1 Substituted diaminopyrimidines
03/23/2005EP1515951A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors
03/23/2005EP1515730A1 Novel maxi-k channel blockers, methods of use and process for making the same
03/23/2005EP1515724A1 Mitotic kinesin inhibitors
03/23/2005EP1515722A2 Ophthalmic compositions for treating ocular hypertension
03/23/2005EP1105120B1 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION
03/23/2005EP1028949B1 Carbamoylphenylsulfonyl ureas, method for their production and their application as herbicides and plant growth regulators
03/23/2005CN1599734A 3, 4-di-substituted maleimide compounds as CXC-chemokine receptor antagonists
03/23/2005CN1599733A N-ureido-piperidines as antagonists viii for CCR-3 receptor
1 ... 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 ... 694